FDA Inspection 1219575 — Walter M. Stadler, M.D.
The FDA completed an inspection of Walter M. Stadler, M.D. on Sep 14, 2023 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 14, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chicago, IL (United States)
Additional details
Clinical Investigator (CI)